CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis

被引:13
作者
Okuyama, Kohei [1 ]
Fukushima, Hiromasa [2 ]
Naruse, Tomofumi [1 ]
Yanamoto, Souichi [1 ]
Tsuchihashi, Hiroki [1 ]
Umeda, Masahiro [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528588, Japan
[2] Nagasaki Univ, Sch Dent, Nagasaki, Japan
基金
日本学术振兴会;
关键词
CD44; variant; 6; Tumor budding; Mandibular gingival squamous cell carcinoma; Medullary invasion; Cervical lymph node metastasis; BONE INVASION; STAGING IMPLICATIONS; TONGUE; PROGNOSIS;
D O I
10.1007/s12253-018-0529-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral squamous cell carcinoma (OSCC) with invasion into the mandibular medullary space has been reported to be a predictive factor for cervical lymph node metastasis (CLNM). As CLNM has been associated with the stemness of cancer cells, we aimed to evaluate the relationship between clinical characteristics and immunohistochemical findings on the invasion front of the medullary invasive OSCC and CLNM. The medical records of 25 patients with the mandibular medullary invasive OSCC who were performed mandibulectomy and neck dissection in our department from 2010 to 2016 were examined. Serial sections were stained with antibodies against CD44 variant 6 (CD44v6) to examine cancer stemness and to evaluate the number of tumor buds in the medullary invasion front of the mandibular invasive OSCC. Categorical data were analyzed by Fisher's exact test. The expression of CD44v6 and the number of tumor buds between the groups with and without pathological CLNM (CLNM+ and CLNM-, respectively) were analyzed using the Mann-Whitney U test. Of the 25 patients, 11 patients were CLNM+. Of the several measured variables, histologic differentiation of the mandibular invasive OSCC was a significant factor for CLNM+. CD44v6 expression and tumor bud formation in the medullary invasion front of the mandibular invasive OSCC were significantly higher in the CLNM+ group, suggests that both CD44v6 and tumor budding in the medullary invasion front are predictive factors for CLNM.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 44 条
  • [31] Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma
    Ma, Chao
    Zhao, Ji-Zhi
    Lin, Run-Tai
    Zhou, Lian
    Chen, Yong-Ning
    Yu, Li-Jiang
    Shi, Tian-Yin
    Wang, Mu
    Liu, Man-Man
    Liu, Yao-Ran
    Zhang, Tao
    ONCOLOGY LETTERS, 2018, 15 (06) : 9498 - 9506
  • [32] Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion
    Noda, Yuri
    Ishida, Mitsuaki
    Ueno, Yasuhiro
    Fujisawa, Takuo
    Iwai, Hiroshi
    Tsuta, Koji
    BMC CANCER, 2022, 22 (01)
  • [33] Treatment strategy for cervical lymph node metastases from early-stage tongue and floor of the mouth squamous cell carcinoma using tumour budding and depth of invasion as predictors
    Ogawa, Masaru
    Yokoo, Satoshi
    Yamaguchi, Takahiro
    Suzuki, Keisuke
    Seki, Mai
    Shimizu, Takahiro
    Makiguchi, Takaya
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (11)
  • [34] Prognostic Role of Tumor Budding and Worst Pattern of Invasion in Lymph Node Metastasis and Disease-Free Survival in Oral Squamous Cell Cancer Patients: Result from Central India's Regional Cancer Centre
    Badanale, Renuka
    Mohta, Vandana
    Wagh, Aniruddha
    Singh, Kartar
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, 76 (04) : 3261 - 3270
  • [35] Tumor–stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade
    Toshihiko Sakai
    Yuki Saito
    Yoko Tateishi
    Sho Yamazawa
    Osamu Fukuoka
    Kenya Kobayashi
    Go Omura
    Ken Akashi
    Masafumi Yoshida
    Mizuo Ando
    Yasuhiro Ebihara
    Tatsuya Yamasoba
    International Journal of Clinical Oncology, 2022, 27 : 1818 - 1827
  • [36] Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion
    Yuri Noda
    Mitsuaki Ishida
    Yasuhiro Ueno
    Takuo Fujisawa
    Hiroshi Iwai
    Koji Tsuta
    BMC Cancer, 22
  • [37] Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade
    Sakai, Toshihiko
    Saito, Yuki
    Tateishi, Yoko
    Yamazawa, Sho
    Fukuoka, Osamu
    Kobayashi, Kenya
    Omura, Go
    Akashi, Ken
    Yoshida, Masafumi
    Ando, Mizuo
    Ebihara, Yasuhiro
    Yamasoba, Tatsuya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (12) : 1818 - 1827
  • [38] Significant association of Yamamoto-Kohama classification and pathological depth of invasion with cervical lymph node metastasis in early-stage tongue squamous cell carcinoma (Stage I/II)
    Kakuguchi, Wataru
    Ashikaga, Yuichi
    Yanagawa-Matsuda, Aya
    Kuribayashi, Kazuyo
    Shinohara, Saki
    Ogawa, Naohiro
    Maishi, Nako
    Hida, Kyoko
    Fang, Chih-Yuan
    Ohiro, Yoichi
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (04) : 1663 - 1668
  • [39] Expression of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Primary Oral Squamous Cell Carcinoma and Corresponding Metastases in Cervical Lymph Nodes: Association with the Metastasis Suppressor CD82
    Kawasaki, Goro
    Yoshitomi, Izumi
    Yanamoto, Souichi
    Yamada, Shin-Ichi
    Mizuno, Akio
    Umeda, Masahiro
    ANTICANCER RESEARCH, 2011, 31 (10) : 3521 - 3526
  • [40] Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors
    Tamatani, Tetsuya
    Takamaru, Natsumi
    Ohe, Go
    Akita, Kazuya
    Nakagawa, Takayuki
    Miyamoto, Youji
    ONCOLOGY LETTERS, 2018, 16 (01) : 1133 - 1140